ID: ALA3356387

Max Phase: Preclinical

Molecular Formula: C39H46ClN5

Molecular Weight: 583.82

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.c1ccc(Nc2cc3nc4ccccc4n(-c4ccccc4)c-3c/c2=N/CCCCCCC23CCCCN2CCCC3)cc1

Standard InChI:  InChI=1S/C39H45N5.ClH/c1(11-23-39-24-12-15-27-43(39)28-16-13-25-39)2-14-26-40-34-30-38-36(29-35(34)41-31-17-5-3-6-18-31)42-33-21-9-10-22-37(33)44(38)32-19-7-4-8-20-32;/h3-10,17-22,29-30,41H,1-2,11-16,23-28H2;1H/b40-34-;

Standard InChI Key:  YQRHMBPNNURWBW-MBMZUTQCSA-N

Associated Targets(non-human)

Leishmania infantum 5912 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Leishmania tropica 461 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Leishmania braziliensis 1091 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasmodium falciparum 966862 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 583.82Molecular Weight (Monoisotopic): 583.3675AlogP: 9.13#Rotatable Bonds: 10
Polar Surface Area: 45.45Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 2HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 9.30CX LogP: 8.94CX LogD: 6.58
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.13Np Likeness Score: -0.52

References

1. Barteselli A, Casagrande M, Basilico N, Parapini S, Rusconi CM, Tonelli M, Boido V, Taramelli D, Sparatore F, Sparatore A..  (2015)  Clofazimine analogs with antileishmanial and antiplasmodial activity.,  23  (1): [PMID:25497962] [10.1016/j.bmc.2014.11.028]

Source